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The characterization of the mechanical properties of cells has many broad 
applications since cell elasticity can indicate pathological state. Notably, many diseases 
cause significant changes in mechanical properties; principally, at the onset of a malaria 
infection, the invading parasites decrease the deformability of Red Blood Cells (RBCs) 
through a variety of structural and molecular changes. Thus, given the difference in 
mechanical properties between healthy RBCs and malaria infected RBCs (iRBCs), there 
exists the potential to separate human blood by stiffness via a microfluidic platform in 
order to develop a more sensitive malaria diagnostic test. We report a statistical 
difference in cell elasticity between RBCs and chemically stiffened iRBCs, which mimic 
the pathophysiology of malaria infection, through the use of Atomic Force Microscopy. 
We also demonstrate preliminary stiffness-dependent separation of RBCs and chemically 
mimicked iRBCs via microfluidic technology. The future successful completion of this 
technique directly aids the long-term objective of this project, which is to develop point-
of-care microfluidic technologies for malaria diagnosis and population surveillance that 










With over 3.3 billion people at risk for infection, malaria is one of the world’s 
deadliest infectious diseases, causing more than one million deaths per year1. In 
developing countries, over 95% of these deaths are caused by the lack of proper diagnosis 
and subsequent improper treatment1. Thus, the development of low-resource diagnostic 
tools for developing countries has emerged as a key focus of public health disease 
diagnosis and surveillance initiatives2,3,4,5. In particular, microfluidic point-of-care (POC) 
diagnostics can be used to detect and monitor infectious diseases in resource-limited 
areas because they can be easily used in rural endemic areas and allow for real-time 
monitoring of disease transmission. Recent development in microfluidic technology has 
provided more opportunities for low cost, high-throughput, POC medical diagnostic 
tools2,3,4,5. 
Malaria is a mosquito-borne infectious disease caused by the invasion and 
multiplication of parasitic Plasmodium protozoans within Red Blood Cells (RBCs)6,7. 
RBCs can be considered elastic bodies since they must significantly deform as they pass 
through capillaries3. However, the mechanical properties of RBCs drastically change 
during malaria infection, which causes increased membrane rigidity and decreased 
deformation6,8,9. In addition to increased stiffness due to the inclusion of the parasite, the 
infected RBC (iRBC) can also be stiffened though the presence of crosslink actin in the 
cytoskeleton9. This variance in cell stiffness is significant at a microscopic scale, ranging 
from 3-50 times stiffer than healthy RBCs, and can used to differentiate otherwise 
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identical populations8,10. This variance in stiffness occurs since RBC elasticity is affected 
by both the stage of parasite maturation inside the RBC and by the blood parasitemia8. 
Thus, given the difference in mechanical properties between healthy RBCs and 
iRBCs, there exists the potential to separate human blood through microfluidics in order 
to better detect malaria. Specifically, this study initially aims to (1) empirically measure 
the difference in stiffness between RBCs and abnormally stiffened RBCs through the use 
of Atomic Force Microscopy and (2) mechanically separate RBCs and stiffened RBCs 
via microfluidic channels. These results will aid in the long-term objective of this project, 
which is to develop microfluidic technologies for malaria diagnosis that improves on the 
sensitivity of the existing malaria Rapid Diagnostic Tests (RDTs). If successful, a more 
sensitive diagnostic device, capable of malaria detection earlier than the current standard, 
will be developed. By detecting malaria earlier, such as in potentially asymptomatic 
individuals, enhanced population surveillance will be possible. 
Malaria 
Malaria is a major cause of human suffering and mortality. In particular, malaria 
is an infectious disease that threatens approximately 3.3 billion people and causes 1 
million deaths annually3,11,12,13,14. As shown in Figure 1, malaria is endemic in over 106 
countries and territories, the majority of which are considered to be developing 
nations11,12. Malaria is endemic in these regions because tropical and subtropical climate 
conditions, including frequent rainfall and warm temperatures, provide ideal habitats for 
mosquito larvae that host the malaria parasites3,6,11,12,13,14.  
Malaria is caused by the invasion and multiplication of parasitic protozoans of the 
genus Plasmodium within RBCs1,6,8,9,11,15. Specifically, there are five species of 
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Plasmodium that can infect and be transmitted by humans. Of these, P. falciparum and P. 
vive cause the majority of the deaths, while P. ovule, P. malaria, and P. Knowles produce 
a milder form of malaria that is rarely fatal6,7,15. 
Figure 1. The Global Presence of Malaria11. Red indicates an endemic country or territory. 
 
The Plasmodium parasites are transmitted via the bite of infected Anopheles 
mosquitos, which inject a motile infective form of the parasite (sporozoites) via their 
saliva into a human’s circulatory system during a blood meal6,7,11,15. Once in the blood, 
the sporozoites travel to the liver for an initial infection phase, during which they mature 
and reproduce asexually to generate thousands of merozoites. Once the merozoites 
rupture the hepatocytes, they return to the bloodstream to infect and reproduce in RBCs. 
In particular, merozoites develop into ring forms (early stage), trophozoites, and 
schizonts to continue parasitic propagation in the human host, as well as develop into 
gametocytes, which allow for continued propagation outside of the human host as the 
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parasite looks for a new 
vector. Gametocytes are 
taken up with blood when a 
fertilized mosquito feeds on 
an infected human, allowing 
for the development of 
sporozoites in the new 
mosquito’s gut3,6,7,11,15. A 
more detailed description of 
the malaria life cycle can be 
seen in Figure 2.  
    
 
Symptoms and Diagnosis 
Symptoms of malaria generally emerge 8-25 days following infection1,2,6,13,15. As 
a result, the blood infection phase is also known as the diagnostic phase since most 
individuals appear asymptomatic during the short liver infection phase1,2,3,4,5. Initial 
manifestations of malaria mimic the flu with symptoms including headache, fever, joint 
pain, and vomiting; as such, early stage malaria can resemble a number of other common 
diseases. More advanced malaria can induce symptoms such as paroxysm, or a sudden 
coldness followed by chills and then recurrent fever, and serious complications including 
respiratory distress and neurological symptoms (cerebral malaria)11,12,13,14,15. Malaria is 
especially fatal to children, with more than 90% of all fatalities occurring in children15. 
Figure 3 shows a Ugandan child suffering from malaria. Uganda has the highest 
Figure 2. Malaria Life Cycle23 
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prevalence of malaria 
compared to other 
endemic countries with 
approximately 9.8 






Figure 3. Ugandan child suffers from malaria16 
 
Given its non-specific clinical symptoms, malaria diagnosis in endemic countries 
remains difficult8,13,14. Currently, malaria is confirmed by microscopy or by antigen-
based RDTs (Figure 4)13,14. Microscopy, or the microscopic examination of blood films 
for the presence of Plasmodium parasites, is the most commonly used method to confirm 
a malaria infection11,13. However, despite its widespread use, correct diagnosis in rural 
endemic settings is difficult due to the lack of proper facilities and trained technicians to 
process the results since the accuracy of microscopy is highly correlated with the skill of 
the person examining the blood films14. In fact, it has been shown that the sensitivity of 
blood films range from 75-90% in optimal settings to 50% in suboptimal settings such as 
in rural developing countries8,11,12,13,14. Although RDTs require little to no training to use, 
deliver results within an hour, and are often more accurate than microscopy, they are 
highly variable in diagnostic sensitivity and specificity from company to company13,14. 
Specifically, although RDTs may be more specific than other current diagnostic methods, 
they are not sensitive enough to detect asymptomatic individuals1,2,3,4,5. Increased  
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Figure 4. Current Malaria Diagnosis Methods including Rapid Diagnostic Tests and Microscopy. 
 
detection sensitivity is needed for early malaria diagnosis and enhanced disease  
surveillance12,16. In fact, current RDTs can only detect 200 parasites/µL, which correlates 
to a more advanced stage of malaria infection and, in the majority of cases, correlates 
with a state that can also be diagnosed clinically17,18,19. 
 Due to the lack of sensitive point-of-care diagnostic tools and the high costs of 
current diagnostic tools and a lack of adequate facilities, clinical diagnosis remains the 
most frequently used method of detection in developing countries despite being 
imprecise1,12,13,14,17,18,19. However, more than 30% of infected individuals will arrive at a 
medical facility with no fever when seeking treatment20. As such, it was reported that 
over 95% of all malaria cases go misdiagnosed and mistreated each year12,13,20.  
Recent advancements in POC diagnostic tools, which specifically target 
developing country environments, have attempted to close this gap14. Nevertheless, 
despite advancements in increasing specificity, including RDTs that can identify the 
particular strain of malaria, little improvements have been made to increase the 
sensitivity of the detection method17,18,19. As WHO has made increased malaria 
surveillance one of its top priorities, being able to detect malaria in asymptomatic 
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individuals has emerged as an important goal12,16,21. One way to achieve this goal is to 
decrease the number of parasites/µL needed to detect malaria to levels that correspond 
with early stage malaria infection12,21. 
Red Blood Cell Deformability 
RBCs can be considered elastic bodies since they must significantly deform as 
they pass through capillaries3. However, the mechanical properties of RBCs drastically 
change during malaria infection, which causes increased membrane rigidity and 
decreased deformation6,8,9. Principally, it has been found that cell deformability plays a 
major role in the pathogenesis of malaria because, at the onset of malaria infection, the 
parasitic inclusion and maturation processes cause cellular and molecular changes, 
drastically reducing RBC deformability3,8. Specifically, based on the stage of parasite 
maturation in the erythrocyte, iRBCs range from 3-50 times more stiff than healthy 
RBCs8. In addition to increased stiffness due to the inclusion of the parasite, the infected 
RBC (iRBC) can also be stiffened though the presence of crosslink actin in the 
cytoskeleton9. Thus, since RBC deformability has important implications for disease 
pathology, this knowledge can be exploited to better understand and diagnose malaria 
infections1,2,3,45,8,9. Relevant to this study, it has been determined that this variance in cell 
stiffness is significant at a microscopic scale and can be differentiated8,10. Quantifying 
this difference in RBC deformability during a malaria infection could allow for earlier 
diagnosis of malaria via enrichment of iRBCs from healthy RBCs. 
Bow (2011) discusses commonly used methods to study RBC deformation 
including filtration and laser diffraction ellipsometry. However, these methods are not 
useful in clinical situations since the number of iRBCs will be small compared to the 
 8 
larger population of healthy RBCs. Thus, other methods such as Atomic Force 
Microscopy (AFM), optical stretching, and optical tweezers should be used. Although 
Bow (2011) discusses several of these methods for examining RBC and iRBC elasticity, 
he ultimately choses to design a microfabricated device similar to a single micropipette 
aspirator. Although Bow certainly avoids treating the RBCs as a static system by 
developing his own device, his results were not significantly different from other 
methods that are easier and less time intensive to quantify baseline RBC deformability. 
Thus, he does not make a cogent argument against using simpler methods to quantify 
stiffness and deformability. As a result, AFM will be used in this study to determine RBC 
deformation. 
Moreover, Eaton (2011) notes that the initial hepatocyte (liver cell) infection by 
the Plasmodium parasite is a clinically silent, obligatory step of the parasite’s life cycle. 
Since hepatocyte infection occurs before RBC parasitic infection, Eaton hypothesizes that 
demonstrating that malaria infected liver cells also exhibit a change in deformability 
similar to that of iRBCs (Eaton 2011) could allow for the development of microfluidic 
diagnostic tools with the ability to diagnose malaria even earlier than the initial RBC 
infection stage. Whether liver stage diagnosis of malaria is clinically possible or 
necessary remains unknown. Given the limited time between infection of liver cells and 
RBCs, it is possible that focusing on changes in RBC deformability to diagnose malaria, 
instead of focusing on changes in hepatocyte deformability, will be just as clinically 
relevant and important for early malaria diagnosis. Moreover, it is clinically  
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simpler to obtain a blood sample than a 
hepatocyte sample from an infected 
individual in a rural, developing setting.  
Atomic Force Microscopy 
Atomic Force Microscopy 
(AFM) is a highly sensitive tool for 
measuring cell deformation or stiffness 
(force spectroscopy). Young’s Modulus 
is calculated as a mechanical probe, or 
cantilever, indents into a cell and the 
resulting piezoelectric displacement 
is measured using the reflection of a laser into an array of photodiodes (Figure 5). This 
extension and retraction of the cantilever is recorded onto a force versus indentation 
graph. The slope of the curve after the cantilever makes contact with the cell is then used 
to determine Young’s Modulus through a Hertz contact model. 
Ebner’s paper (2011) discusses the use of Atomic Force Microscopy (AFM) with 
regards to determining cell deformability. Specifically, he discusses the different AFM 
techniques that can be used to investigate healthy and pathological RBCs. This study set 
a precedent for ensuring the immobilization of whole, intact RBCs for analysis as it 
reported the importance of maintaining cell viability and proper cell culture conditions 
when conducting AFM measurements in order to better mimic normal, healthy cell 
environments. It has been shown that extensive changes in temperature, pH, and media 
content can alter cell stiffness. Thus, Ebner clearly demonstrates the need to limit 
Figure 5. Atomic Force Microscopy General Overview 
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environmental changes such that a static model (AFM) can be applied to a dynamic 
system (RBC in body).  
Microfluidic Platforms 
The majority of research teams currently developing deformability-based 
diagnostic tools are using microfluidic platforms. Microfluidic devices precisely 
manipulate geometrically contained fluids for separation at the micrometer scale. In 
particular, it has been found that when using deformability as the separation factor, 
continuous-flow microfluidics are easier to implement and more sensitive than protein-
sensing alternatives1,4,5. While microfluidic platforms were originally developed for use 
within the field of cancer diagnostics, given that it was one of the first diseases with a 
quantified difference in elastic modulus between healthy and malignant cells, the 
technology has since been applied to other diseases given increased knowledge of the 
changes in cellular mechanics other diseases. 
Gascoyne (2004) and his research assistants were the first research team to 
recognize the ability to apply microfluidic technology to malaria detection. In particular, 
his research team compared the advantages and disadvantages of current malaria 
detection methods and discussed their adaptability towards integration with new 
microfluidic devices. Nevertheless, although Gascoyne extensively discussed challenges 
associated with developing better systems for detection, he did not discuss any methods 
to overcome these challenges and produce a viable option for malaria diagnosis/detection. 
Regardless, he concluded that, due to the potential benefits of microfluidic devices, the 
approach is worth pursuing. 
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Since 2004, there have been vast improvements in this research area, and, starting 
in 2010, the application of microfluidics to RBC deformability-based separation has 
become much more mainstream. Sha Huang and Han Wei Hou direct two prominent 
research groups working on this topic.  
Huang (2010) looks at the difference in stiffness of healthy RBCs and iRBCs in 
microfluidic devices as a function of temperature. Specifically, he found that while 
iRBCs are less deformable than healthy RBCs at all temperatures, this difference in 
stiffness is maximized at 40 degrees celcius. Understanding this change in stiffness, 
perhaps due to the presence of a fever when infected with Malaria, is important to 
understanding how the malaria Plasmodium parasite alters the cell mechanics. 
Furthermore, Huang indicates that using warmer RBCs in microfluidic “deformability 
cytometry" could lead to improved malaria microfluidic diagnostics due to the larger 
statistical difference in stiffness. 
Han Wei Hou has produced several papers on the application of microfluidic 
platforms for malaria detection over the past two years. In 2011, he reported several 
issues to be considered when designing a microfluidic, POC device for malaria detection. 
Specifically, he highlighted the importance of initial blood separation in order to enrich a 
certain aspect of the blood. This method is important since by separating healthy RBCs 
and iRBCs, it is possible that malaria could be detected earlier by using the aggrate to 
enrich the changes in stiffness found in the iRBC population. Enriching the iRBC 
population is crucial for the study’s aim to improve the sensitivity of the current malaria 
RDT since it could allow for detection of malaria at levels around 10 parasites/µL (1/20 
of the current sensitivity). Moreover, in 2012, Hou specifically addresses the issue of 
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platlet and White Blood Cell (WBC) filtration from whole blood. When looking for 
pathogen removal of a system, or pathogen separation for diagnostics, it is important to 
isolate the pathogen or marker cell. Thus, having some sort of filtration system prior to 
Red Blood Cell (RBC) separation will greatly aid in a POC malaria diagnostic, 





Red Blood Cell Preparation 
Reagents 
Citrate-dextrose solution (ACD), Poly-L-lysine (PLL), diamide (DIA), 
formaldehyde (FMA), and glutaraldehyde (GLA) were obtained from Sigma-Aldrich. 
Dulbecco’s Phosphate Buffered Saline (DPBS) was obtained from Invitrogen. 
Cell Culture 
Whole blood was obtained by venipuncture from normal healthy donors of 
various blood types and treated immediately with 0.5% (by volume) ACD to prevent 
clotting. Blood was stored at 37°C until use. All experiments were conducted within 2 
hours of the initial blood donation to prevent any inhibiting effects from using old blood. 
RBC Isolation 
RBCs were isolated (Figure 6) from whole blood through centrifugation at 1000 
RCF for 10 minutes. The isolated RBCs were subsequently washed twice with DPBS. 
RBCs were diluted to a concentration of 1 million/mL for treatment with the various 
drugs that mimic the stiffening pathophysiology of malaria iRBCs. RBCs were diluted to 
a concentration of 50 million RBCs/mL for separation experiments and to a concentration 
of 3,000 RBCs/mL for AFM experiments. All RBC solutions were diluted in DPBS. 
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RBC Preparation 
Four experimental groups were used: 
normal healthy RBCs and three different 
chemically mimicked iRBCs. The 
chemically treated RBCs mimicked the 
stiffening pathophysiology during malaria 
infection. Healthy RBCs were defined as the 
normal, untreated RBC population. 
Chemically micked iRBCs were created 
through treatment with (1) 4% FMA for 30 
minutes at room temperature, (2) 4% GLA for 30 minutes at room temperature, and (3) 
40 µM DIA for 20 minutes on ice. After treatment, the chemically mimicked iRBCs were 
subsequently washed twice with DPBS. 
Atomic Force Microscopy 
Atomic Force Microscopy (AFM) was used to determine the deformability of 
RBCs. All RBCs were measured in 
a suspended state. Following RBC 
isolation, 3,000 RBCs were 
removed from each sample to create 
a cell suspension in 3 mL DPBS as 
shown in Figure 7. Glass AFM  
Figure 6. Red Blood Cell Isolation 
Figure 7. Red Blood Cell Suspension in AFM Fluorodish 
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Figure 8. MSCT Triangular Silicon-Nitride Cantilever. A) Cantilever was beaded with a 5µm silica 
bead B) Cantilever during RBC elasticity measurements 
 
fluorodishes (World Precision Instruments) were treated with 0.01% PLL prior to the 
addition of the RBC solution for enhanced cell plating. The monolayer of PLL on the 
fluorodish enhanced the ability to take AFM measurements by lightly attaching the cells 
to the glass without altering RBC morphology. Deformability measurements were 
collected using a MFP-3D AFM (Asylum Research) attached to an inverted optical 
microscope (Nikon Eclipse Ti) and a triangular, silicon nitride MSCT cantilever 
(Bruker). The cantilever (Figure 8) was calibrated using a thermal vibration method to 
determine the spring constant (0.03 N/m) and was positioned above the center of a single 
RBC prior to indentation. Individual RBCs (n=25) were indented 0.1 µm by the 
cantilever. Three force-indentation curves were generated for each measured RBC; the 
slope of each curve was then analyzed using a Hertz contact model for a pyramidal tip to 




Figure 9. Microfluidic Device (Life Size). Image shows the high-throughput microfluidic device used for 
the stiffness-dependent separation of RBCs for early malaria detection. 
 
Separation Experiments 
 Microfluidic devices (Figure 9) were designed and fabricated as previously 
described21. The microfluidic platform was developed based on a separation principle in 
which cells flowing through the microchannel are deformed by the periodic ridges which 
are skew to the channel. This elastic deformation produces a resultant mechanical force 
along the direction of the ridges. Stiff cells experience greater ridge-induced force, 
resulting in a greater transverse displacement parallel to the diagonal ridges; soft cells 
experience little ridge-induced force, resulting in a smaller transverse displacement 





Figure 10. Microfluidic Device Concept Overview. Healthy and chemically stiffened RBCs were mixed 
prior to flowing. Using a microfluidic platform developed in conjunction with a computational Lattice 
Spring Model (LSM), cells were sorted by stiffness. Stiff cells (chemically mimicked iRBCs) were 
collected in the top outlet, while soft cells (healthy RBCs) were collected in the bottom outlet. 
 
Biomechanical separation was tested using syringe pumps to control the flow rates of 
both the cell solution and cell focusing sheaths across the microchannels (Figure 10). 
Single flow separation experiments occured first; during these experiments, normal RBCs 
and chemically mimicked iRBCs were separated individually through microfludic 
devices with varying gap sizes at a range of flow rates. After identifying the ideal flow 
rate and gap size for the microfluidic technology, the specific cell trajectories, illstrating 
the amount and direction of transverse displacement, were calculated to illustrate the 
ability to separate the two otherwise identical populations. Once the ability to separate 
two populations was confirmed by comparing net transverse displacement per ridge, 
combined solutions of both RBC and iRBCs populations were separated.  
Red Blood Cell Size Determination 
 To ensure that we were separating populations that only varied by elasticity, not 




 Red Blood Cell Size 
 RBCs were imaged using phase contrast microscopy at 40x. Images were then 
processed via ImageJ software to determine the average RBC diameter of each treatment 
group (healthy, DIA-treated, FMA-treated, and GTA-treated RBCs). It was determined 
that there was no statistical difference (p>0.05) in cell size between the four groups. In 
particular, healthy RBCs had an average diameter of 8.82 ± 0.50 µm, DIA-treated RBCs 
had an average diameter of 8.63 ± 0.62 µm, FMA-treated RBCs had an average diameter 
of 8.64 ± 0.64 µm, and GTA-treated RBCs had an average diameter of 8.73 ± 0.62 µm. 








Figure 11. Representative Images of Red Blood Cell Morphology and Size. A) DIA-treated 
RBCs B) FMA-treated RBCs C) healthy RBCs D) GTA-treated RBCs. No statistical differences 
were found in cell size between any of the tested groups, confirming that each group only differs in 










Red Blood Cell Young’s Modulus 
Atomic Force Microscopy (AFM) was used to calculate the Young’s Modulus of 
healthy RBCs and chemically mimicked iRBCs. Baseline elasticity measurements 
(Figure 12) for healthy RBCs and chemically stiffened RBCs (n=25) showed a 
significant statistical difference (p<0.001) between all tested groups. In particular, 
healthy RBCs (E= 0.102 ± 0.043 kPa) were found to be statistically more deformable 
than DIA-treated RBCs (E= 1.867 ± 0.728 kPa), FMA-treated RBCs (E= 4.267 ± 1.608 
kPa), and GTA-treated RBCs (E= 18.513 ± 7.761 kPa) (Table 1). This further 
demonstrated that two of the selected drug treatments, DIA and FMA, could correctly 
mimic the stiffening pathophysiology of early iRBCs since they were found to have a 
Figure 12. Deformability Results of Red Blood Cells. RBCs were treated with various drugs (DIA, 
FMA, and GTA) to simulate the stiffening pathophysiology during a malaria infection. Young’s 
Modulus was measured using Atomic Force Microscopy in conjunction with a Hertz contact model.  
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Young’s Modulus within the desired literature range of 3-50 times less deformable than 
healthy RBCs8. 
Type of RBC Young’s Modulus Comparison of Elasticity 
Healthy RBCs 0.102 ± 0.043 kPa --- 
DIA-treated RBCs 1.867 ± 0.728 kPa 18x 
FMA-treated RBCs 4.267 ± 1.608 kPa 42x 
GTA-treated RBCs 18.513 ± 7.761 kPa 185x 
Table 1. Deformability of Red Blood Cells 
 
Red Blood Cell Separation Experiments 
 Single flow experiments of only one experimental RBC population were 
conducted first to ascertain the correct parameters for separation, including flow rate and 
device dimensions, particularly the gap distance between the ridges and the bottom of the 
channel. Specifically, normal RBCs and chemically stiffened RBCs were separated 
individually through microfludic devices with varying gap sizes (2, 4, 6, and 8 µm) at a 
range of flow rates (0.0001, 0.0005, 0.001 mL/min). It was found that the healthy RBCs 
exited the device in the bottom inlet for all test cases; however, the three chemically 
stiffened populations experienced varied effects. The FMA-treated RBCs exited at the top 
outlet, typical of stiff cells, at gaps of 2 and 4 µm and with all flow rates of 0.0001 
mL/min. The GTA-treated RBCs only exited at the top outlet at gaps of 2 and 4 µm and 
with flow rates of 0.0001 mL/min. The DIA-treated cells did not exhibit any downwards 
displacement at any of the tested gap size or flow rates. Thus, the device constaints for  
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Figure 13. Single Flow Trajectory Results. The trajectories of single RBCs over the device’s periodic 
ridges were analyzed by calculating the net transverse displacement per ridge. This displacement value and 
direction was then used to determine the ability to separate two RBC populations if combined. 
 
separation were determined to be a device with gaps between ridges of 2-4 µm that used 
low flow rates of 0.0001 mL/min.  
 Using the results of flowing single populations of RBCs at this gap size and flow 
rate, the specific RBC trajectories over the periodic ridges were analyzed by calculating 
the net transverse displacement per ridge (Figure 13). Healthy RBCs had a net negative 
displacement of -2.08 µm, DIA-treated RBCs had a net negative displacement of -0.93 
µm, and FMA-treated RBCs had a net positive displacement of 3.92 µm. These 
displacement results demonstrated the ability to separate healthy RBCs and FMA-treated  
RBCs given that healthy RBCs experienced negative displacement while FMA-treated 
RBCs experienced positive displacement. Thus, subsequent separation experiments 
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(Figure 14) were conducted using combined solutions of both RBC and iRBCs 
populations with a 4 µm device  and a 0.0001 mL/min inlet flow rate. However, despite 
theoretical confirmation of the ability to biomechanically separate the two populations, 
preliminary visual results have not exhibited the expected outcome: it could not be 




Figure 14. Combined Solution Separation Experiment Overview. Healthy RBCs and FMA-treated 
RBCs were combined and flowed through the microfluidic platform. It was expected that the stiff cells 
(mimicked iRBCs) would have a net positive displacement and be collected in the top outlet, while the 
soft cells (healthy RBCs) would have a net negative displacement e collected in the bottom outlet. 





Red Blood Cell Deformability 
 Given this significant difference in RBC elasticity among all groups (p<0.001), 
and the fact that the chemically treated RBCs ranged from 3-50 times less deformable 
than the healthy RBCs, it was determined that two of the selected drug treatments (FMA 
and DIA) could correctly mimic the stiffening pathophysiology of iRBCs. In particular, 
the various stages of a malaria infection can be indicated via differences in RBC 
deformability: as the parasite matures in the RBC and/or the parasitemia of the blood 
increases, the difference in stiffness between iRBCs and RBCs also increases. Thus, the 
statistical difference (p<0.01) between mimicked iRBC treatment groups illustrated that 
there were four distinct populations. Given that the three treated RBC populations had 
Young’s Moduli that ranged from 3-50 times less deformable than the healthy RBC 
population, it was determined that the three experimental groups could simulate various 
stages of the stiffening pathophysiology of iRBCs. Furthermore, given this significant 
nanomechanical difference in elasticity among all groups, it was determined that the four 
RBC populations could be differentiated on a microscopic scale using stiffness-based 
microfluidic separation. 
Red Blood Cell Separation  
The single flow experiments confirmed the ability of the proposed microfluidic 
device to separate otherwise identical populations of RBCs that only varied by stiffness. 
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Particularly, this was confirmed by tracking the different RBC trajectories through the 
microfluidic device from inlet to outlet and calculating the net transverse displacement of 
the various RBC populations (Healthy, DIA, FMA, and GTA). Healthy RBCs had a net 
negative displacement of -2.08 µm, DIA-treated RBCs had a net negative displacement 
of -0.93 µm, and FMA-treated RBCs had a net positive displacement of 3.92 µm. 
These displacement results demonstrated the ability to separate healthy RBCs and FMA-
treated  RBCs given that healthy RBCs experienced negative displacement while FMA-
treated RBCs experienced positive displacement.  
 Furthermore, the displacement results were used to ascertain the theoretical ability 
to separate two experimental populations (Healthy vs. DIA, FMA or GTA) that only 
varied in elasticity by using a microfluidic platform. Given theoretical confirmation of 
the ability to biomechanically separate healthy and FMA-treated RBCs, preliminary 
separation experiments of combined solutions were conducted. Regardless, preliminary 
visual results did not exhibit the expected theoretical outcome: it was not quantitatively 
determined that the two populations could be separated from each other using 
highthroughput biomechanical separation. This inability to quantiatively demonstrate 
separation of identical populations of RBCs that only varied by stiffness (E= 0.102 kPa 
and E= 4.267 kPa) at a throughput of 200 million cells/min could be due to several 
confounding factors.  First, given that RBCs are not perfect spheres, their ridge-induced 
translation might not respond as predicted by computational simulations. In additional, 
due to the high flow rates, the dynamic stiffness may be different than the values 
determined with AFM. Moreover, it is possible that the device’s dimensions were not 
fully optimized for this non-spherical RBC shape; separation could occur by further 
 25 
adjusting the gap height. Finally, the RBC stains were not optimized as we observed co-
staining of both cell populations after separation occurred. We anticipate that 
improvements in cell staining and more exact device parameters will lead to significantly 





Red Blood Cell Deformability 
 It was found that there exists a significant difference in elasticity between healthy 
RBCs and chemically mimicked iRBCs (RBCs treated with DIA, FMA or GTA). This 
significant elasticity variance mimics the natural change in cellular mechanical properties 
during a malaria infection, which causes increased RBC membrane rigidity and decreased 
deformation. It was shown that this variance is significant at a microscopic scale and can 
be exploited for diagnostic purposes via stiffness-dependent cell separation resulting in 
population differentiation and enrichment of the number of parasites per milliliter. 
Red Blood Cell Separation Experiments 
 It was determined that a microfluidic platform that separates cells by mechanical 
stiffness can be successfully employed. Particularly, it was shown that the periodic ridges 
of the microfludic device deform RBCs and that this elastic deformation allows for 
stiffness-dependent separation by producing mechanical forces along the ridges that act 
on soft and stiff cells differently: stiff cells experience this ridge-induced force, resulting 
in transverse displacement parallel to the diagonal ridges, while soft cells experience little 
ridge-induced force, resulting in transverse displacement perpendicular to the diagonal 
ridges. Thus, it was determined that the separation of healthy and FMA-treated RBCs, 
which mimic early stage iRBCs, can occur. This result was used to initiate preliminary 
separation experiments of two combined RBC populations: healthy RBCs and FMA-
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treated RBCs. However, combined separation experiments of healthy RBCs and FMA-
treated RBCs did not yield the expected theoretical separation/enrichment results. Rather, 
it was visually determined in all trials that separation did not occur. Thus, several future 
changes must occur in order to ensure the experimental combined RBC separation results 





Combined Solution Separation Experiments 
 Given initial that preliminary combined separation experiments did not exhibit the 
expected separation outcome, future studies will specifically address potential 
counfounding factors or barriers to the combined separation of healthy RBCs and FMA-
treated RBCs. For example, since RBCs are not perfect spheres, their ridge-induced 
translation might not respond as predicted by computational simulations. In additional, 
due to the high flow rates, the dynamic stiffness may be different than the values 
determined with AFM. Moreover, it is possible that the device’s dimensions were not 
fully optimized for this non-spherical RBC shape; thus, separation could occur by further 
adjusting the gap height, not just the gap width. Finally, since the results of the combined 
separation experiments were visually determined and we observed co-staining of both 
cell populations after separation occurred, future studies will utilize optimized RBC 
stains to quantitatively determine percent population both prior and post separation. Thus, 
we anticipate that improvements in cell staining and more exact device parameters will 
lead to significantly improved RBC enrichment. These future results will enable the 
future development of microfluidic technologies for malaria diagnosis and population 
surveillance that improve on the sensitivity of the current Rapid Diagnostic Test (RDT). 
If successful separating mimicked iRBC separation from healthy RBCs, subsequent 
stages of this study will transition to separating malaria blood samples, which contain 
both healthy RBCs and actual malaria iRBCs. 
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Whole Blood Separation Experiments 
 If successful with combined solution separation, future studies will also transition 
to whole blood separation to better mimic potential point-of-care field use for malaria 
detection. Currently, RBCs are isolated from whole blood and diluted x50 to ensure that 
the device does not clog. However, the isolation and dilution of RBCs requires both 
training and laboratory equipment. Thus, it is not always possible or desired in endemic, 
developing areas. It is crucial that this step either be minimized or removed to better 
facilitate ease-of-use and, as a result, increase the liklihood that the device will be used to 
diagnose and enhance surveillance of malaria in neglected areas. In order to achieve this, 
additional alterations to the exisiting device must be considered. For example, a 
preliminary while blood cell filter must be added to isolate RBCs from the whole blood 
population prior to separation via the diagnoal ridges.
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APPENDIX A 
SINGLE FLOW RBC TRAJECTORY VIDEO 





RBC SEPARATION VIDEO 
This file illustrates the two trajectories of a combined solution of healthy RBCs and 
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